| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-46603SS | |||
| BSA Free | NBP2-46603 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-87426-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-81035-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-85335-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-84827-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-86168-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74798 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-79127-25ug | |||
![Western Blot: KIF2C Antibody (1G2) [H00011004-M01] - KIF2C monoclonal antibody (M01), clone 1G2 Analysis of KIF2C expression in Hela S3 NE.](http://images.novusbio.com/fullsize/KIF2C-Antibody-1G2-Western-Blot-H00011004-M01-img0014.jpg "Western Blot: KIF2C Antibody (1G2) [H00011004-M01] - KIF2C monoclonal antibody (M01), clone 1G2 Analysis of KIF2C expression in Hela S3 NE.")
![Immunocytochemistry/Immunofluorescence: KIF2C Antibody (1G2) [H00011004-M01] - Analysis of monoclonal antibody to KIF2C on HeLa cell. Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/KIF2C-Antibody-1G2-Immunocytochemistry-Immunofluorescence-H00011004-M01-img0008.jpg)
![Immunohistochemistry-Paraffin: KIF2C Antibody (1G2) [H00011004-M01] - Analysis of monoclonal antibody to KIF2C on formalin-fixed paraffin-embedded human malignant lymphoma, diffuse large B. Antibody concentration 3 ug/ml.](http://images.novusbio.com/fullsize/KIF2C-Antibody-1G2-Immunohistochemistry-Paraffin-H00011004-M01-img0010.jpg)
![Western Blot: KIF2C Antibody (1G2) [H00011004-M01] - Analysis of KIF2C over-expressed 293 cell line, cotransfected with KIF2C Validated Chimera RNAi ( Cat # H00011004-R01V ) (Lane 2) or non-transfected control (Lane 1). Blot probed with KIF2C monoclonal antibody (M01), clone 1G2 (Cat # H00011004-M01 ). GAPDH ( 36.1 kDa ) used as specificity and loading control.](http://images.novusbio.com/fullsize/KIF2C-Antibody-1G2-Western-Blot-H00011004-M01-img0012.jpg)
![Western Blot: KIF2C Antibody (1G2) [H00011004-M01] - Analysis of KIF2C expression in transfected 293T cell line by KIF2C monoclonal antibody (M01), clone 1G2.Lane 1: KIF2C transfected lysate(81.3 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/KIF2C-Antibody-1G2-Western-Blot-H00011004-M01-img0015.jpg)
![Immunoprecipitation: KIF2C Antibody (1G2) [H00011004-M01] - Analysis of KIF2C transfected lysate using anti-KIF2C monoclonal antibody and Protein A Magnetic Bead, and immunoblotted with KIF2C MaxPab rabbit polyclonal antibody.](http://images.novusbio.com/fullsize/KIF2C-Antibody-1G2-Immunoprecipitation-H00011004-M01-img0011.jpg)
![Sandwich ELISA: KIF2C Antibody (1G2) [H00011004-M01] - Detection limit for recombinant GST tagged KIF2C is approximately 0.1ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/KIF2C-Antibody-1G2-Sandwich-ELISA-H00011004-M01-img0013.jpg)
![Western Blot: Melan-A/MART-1 Antibody (A103) - Azide and BSA Free [NBP2-80846] - Total protein from human skin, pancreas and kidney and mouse kidney was separated on a 4-20% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 2.0 ug/ml anti-Melan-A in 1% non-fat milk in TBST and detected with an anti-mouse HRP secondary antibody using chemiluminescence. Image from the standard format of this antibody.](http://images.novusbio.com/fullsize/Melan-A-MART-1-Antibody-A103-Azide-and-BSA-Free-Western-Blot-NBP2-80846-img0001.jpg "Western Blot: Melan-A/MART-1 Antibody (A103) - Azide and BSA Free [NBP2-80846] - Total protein from human skin, pancreas and kidney and mouse kidney was separated on a 4-20% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 2.0 ug/ml anti-Melan-A in 1% non-fat milk in TBST and detected with an anti-mouse HRP secondary antibody using chemiluminescence. Image from the standard format of this antibody.")
![Immunohistochemistry-Paraffin: Melan-A/MART-1 Antibody (A103) - Azide and BSA Free [NBP2-80846] - Analysis of FFPE tissue section of Human Skin Cancer/Melanoma using Melan-A/MART-1 antibody (A103) at 1:100 dilution. The antibody depicted very specific staining which was cytoplasmic with strong punctate appearance in peri-nuclear regions (ER and Golgi)](http://images.novusbio.com/fullsize/Melan-A-MART-1-Antibody-A103-Azide-and-BSA-Free-Immunohistochemistry-Paraffin-NBP2-80846-img0003.jpg)
![Flow Cytometry: Melan-A/MART-1 Antibody (A103) - Azide and BSA Free [NBP2-80846] - An intracellular stain was performed on SK-MEL-28 cells with Melan-A/MART-1 [A103] Antibody NBP2-46603AF647 (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were directly conjugated to Alexa Fluor 647.](http://images.novusbio.com/fullsize/Melan-A-MART-1-Antibody-A103-Azide-and-BSA-Free-Flow-Cytometry-NBP2-80846-img0004.jpg)
![Immunohistochemistry: Melan-A/MART-1 Antibody (A103) - Azide and BSA Free [NBP2-80846] - Analysis of FFPE tissue section of Human Skin Cancer/Melanoma using Melan-A/MART-1 antibody (A103) at 1:100 dilution. The antibody depicted very specific staining which was cytoplasmic with strong punctate appearance in peri-nuclear regions (ER and Golgi)](http://images.novusbio.com/fullsize/Melan-A-MART-1-Antibody-A103-Azide-and-BSA-Free-Immunohistochemistry-NBP2-80846-img0002.jpg)
![Flow Cytometry: Melan-A/MART-1 Antibody (A103) - Azide and BSA Free [NBP2-80846] - An intracellular stain was performed on SK-MEL-28 cells with Melan-A/MART-1 Antibody [A103] NBP2-46603F (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 5 ug/mL for 30 minutes at room temperature. Both antibodies were directly conjugated to FITC.](http://images.novusbio.com/fullsize/Melan-A-MART-1-Antibody-A103-Azide-and-BSA-Free-Flow-Cytometry-NBP2-80846-img0005.jpg)
![Immunohistochemistry-Paraffin: Profilin 2 Antibody [NBP1-87426] - Staining in human cerebral cortex and skin tissues using anti-PFN2 antibody. Corresponding PFN2 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/Profilin-2-Antibody-Immunohistochemistry-Paraffin-NBP1-87426-img0012.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: Profilin 2 Antibody [NBP1-87426] - Staining in human cerebral cortex and skin tissues using anti-PFN2 antibody. Corresponding PFN2 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: Profilin 2 Antibody [NBP1-87426] - Analysis in human cell lines A-431 and Caco-2. Corresponding RNA-seq data are presented for the same cell lines. Loading control: Anti-PARP1.](http://images.novusbio.com/fullsize/Profilin-2-Antibody-Western-Blot-NBP1-87426-img0009.jpg)
![Western Blot: Profilin 2 Antibody [NBP1-87426] - Lane 1: NIH-3T3 cell lysate (Mouse embryonic fibroblast cells). Lane 2: NBT-II cell lysate (Rat Wistar bladder tumor cells).](http://images.novusbio.com/fullsize/Profilin-2-Antibody-Western-Blot-NBP1-87426-img0006.jpg)
![Western Blot: Profilin 2 Antibody [NBP1-87426] - Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG sp](http://images.novusbio.com/fullsize/Profilin-2-Antibody-Western-Blot-NBP1-87426-img0007.jpg)
![Immunohistochemistry-Paraffin: Profilin 2 Antibody [NBP1-87426] - Staining of human cerebral cortex shows high expression.](http://images.novusbio.com/fullsize/Profilin-2-Antibody-Immunohistochemistry-Paraffin-NBP1-87426-img0010.jpg)
![Immunohistochemistry-Paraffin: Profilin 2 Antibody [NBP1-87426] - Staining of human skin shows low expression as expected.](http://images.novusbio.com/fullsize/Profilin-2-Antibody-Immunohistochemistry-Paraffin-NBP1-87426-img0011.jpg)
![Immunohistochemistry-Paraffin: MPRIP Antibody [NBP1-81035] - Staining of human cerebral cortex, fallopian tube, liver and prostate using Anti-MPRIP antibody NBP1-81035 (A) shows similar protein distribution across tissues to independent antibody NBP1-81036 (B).](http://images.novusbio.com/fullsize/MPRIP-Antibody-Immunohistochemistry-Paraffin-NBP1-81035-img0018.jpg "<b>Independent Antibodies Validation. </b>Immunohistochemistry-Paraffin: MPRIP Antibody [NBP1-81035] - Staining of human cerebral cortex, fallopian tube, liver and prostate using Anti-MPRIP antibody NBP1-81035 (A) shows similar protein distribution across tissues to independent antibody NBP1-81036 (B).")
![<b>Independent Antibodies Validation. </b>Western Blot: MPRIP Antibody [NBP1-81035] - Analysis in mouse cell line NIH-3T3 and rat cell line NBT-II.](http://images.novusbio.com/fullsize/MPRIP-Antibody-Western-Blot-NBP1-81035-img0009.jpg)
![Immunocytochemistry/Immunofluorescence: MPRIP Antibody [NBP1-81035] - Staining of human cell line A-431 shows localization to actin filaments. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/MPRIP-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-81035-img0010.jpg)
![Immunohistochemistry-Paraffin: MPRIP Antibody [NBP1-81035] - Staining of human prostate shows weak to moderate cytoplasmic positivity in smooth muscle cells.](http://images.novusbio.com/fullsize/MPRIP-Antibody-Immunohistochemistry-Paraffin-NBP1-81035-img0021.jpg)
![Western Blot: MPRIP Antibody [NBP1-81035] - Analysis in human cell line PC-3.](http://images.novusbio.com/fullsize/MPRIP-Antibody-Western-Blot-NBP1-81035-img0008.jpg)
![Immunohistochemistry-Paraffin: MPRIP Antibody [NBP1-81035] - Staining of human cerebral cortex shows moderate cytoplasmic positivity in neuropil.](http://images.novusbio.com/fullsize/MPRIP-Antibody-Immunohistochemistry-Paraffin-NBP1-81035-img0017.jpg)
![Immunohistochemistry-Paraffin: MPRIP Antibody [NBP1-81035] - Staining of human Fallopian tube shows moderate positivity in apical membrane in glandular cells.](http://images.novusbio.com/fullsize/MPRIP-Antibody-Immunohistochemistry-Paraffin-NBP1-81035-img0019.jpg)
![Immunohistochemistry-Paraffin: MPRIP Antibody [NBP1-81035] - Staining of human liver shows moderate cytoplasmic positivity in hepatocytes.](http://images.novusbio.com/fullsize/MPRIP-Antibody-Immunohistochemistry-Paraffin-NBP1-81035-img0020.jpg)
![Western Blot: Villin 1 Antibody [NBP1-85335] - Analysis using Anti-VIL1 antibody NBP1-85335 (A) shows similar pattern to independent antibody NBP1-85336 (B).](http://images.novusbio.com/fullsize/Villin-1-Antibody-Western-Blot-NBP1-85335-img0004.jpg "<b>Independent Antibodies Validation. </b>Western Blot: Villin 1 Antibody [NBP1-85335] - Analysis using Anti-VIL1 antibody NBP1-85335 (A) shows similar pattern to independent antibody NBP1-85336 (B).")
![<b>Independent Antibodies Validation. </b>Immunocytochemistry/Immunofluorescence: Villin 1 Antibody [NBP1-85335] - Staining of human cell line CACO-2 shows localization to plasma membrane. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/Villin-1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-85335-img0002.jpg)
![Immunohistochemistry-Paraffin: Villin 1 Antibody [NBP1-85335] - Staining of human colon.](http://images.novusbio.com/fullsize/Villin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-85335-img0007.jpg)
![<b>Independent Antibodies Validation. </b>Immunohistochemistry-Paraffin: Villin 1 Antibody [NBP1-85335] - Staining of human colon, gallbladder, kidney and liver using Anti-VIL1 antibody NBP1-85335 (A) shows similar protein distribution across tissues to independent antibody NBP1-85336 (B).](http://images.novusbio.com/fullsize/Villin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-85335-img0003.jpg)
![Immunohistochemistry-Paraffin: Villin 1 Antibody [NBP1-85335] - Staining of human liver.](http://images.novusbio.com/fullsize/Villin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-85335-img0005.jpg)
![Immunohistochemistry-Paraffin: Villin 1 Antibody [NBP1-85335] - Staining of human gallbladder.](http://images.novusbio.com/fullsize/Villin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-85335-img0006.jpg)
![Immunohistochemistry-Paraffin: Villin 1 Antibody [NBP1-85335] - Staining of human kidney.](http://images.novusbio.com/fullsize/Villin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-85335-img0008.jpg)
![Immunocytochemistry/Immunofluorescence: Borealin Antibody [NBP1-89951] - Staining of human cell line U-251 MG shows localization to nucleus & nucleoli. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/Borealin-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-89951-img0010.jpg "Immunocytochemistry/Immunofluorescence: Borealin Antibody [NBP1-89951] - Staining of human cell line U-251 MG shows localization to nucleus & nucleoli. Antibody staining is shown in green.")
![Immunohistochemistry-Paraffin: Borealin Antibody [NBP1-89951] - Staining of human testis shows moderate to strong nuclear positivity in cells in seminiferous ducts.](http://images.novusbio.com/fullsize/Borealin-Antibody-Immunohistochemistry-Paraffin-NBP1-89951-img0015.jpg)
![Immunohistochemistry-Paraffin: Borealin Antibody [NBP1-89951] - Staining of human duodenum shows strong nuclear positivity in a subset of glandular cells.](http://images.novusbio.com/fullsize/Borealin-Antibody-Immunohistochemistry-Paraffin-NBP1-89951-img0012.jpg)
![Immunohistochemistry-Paraffin: Borealin Antibody [NBP1-89951] - Staining of human lymphoid tissues shows moderate nuclear positivity in germinal center cells.](http://images.novusbio.com/fullsize/Borealin-Antibody-Immunohistochemistry-Paraffin-NBP1-89951-img0013.jpg)
![Western Blot: Borealin Antibody [NBP1-89951] - Aurora B preferentially binds to H3R2me2a & recruits CPC components.a The amino acid sequences of modified histone H3 peptides. b In vitro Haspin kinase assay w/ 21-aa peptide. c In vitro Aurora B kinase assay w/ 21-aa peptide for phosphorylation. d In vitro PRMT6 methyltransferase assay. e–h The cells treated w/ siPRMT6, PRMT6 inhibitor MS023, or the Haspin kinase inhibitor CHR-6494. The intensities of H3R2me2a (f) & H3T3ph (h) in chromosome arm & centromere analyzed by IF microscopy of nocodazole-arrested HeLa chromosome spreads & plotted (n = 100 chromosomes from three independent experiments). i After transfection of indicated plasmids, HeLa cells treated w/ a Haspin kinase inhibitor, CHR-6494, for 5 h & the intensity of CPC components analyzed for 100 centromeres from three independent experiments. j Recombinant CPC proteins incubated w/ biotinylated histone peptides & pulled down w/ streptavidin-agarose beads, & the binding visualized by immunoblotting. k Lysates of TN-arrested Aurora B-depleted cells supplemented w/ recombinant Survivin & Borealin proteins w/ or w/out recombinant Aurora B protein. The lysates incubated w/ antibodies against INCENP & the H3R2me2a peptide, & pulldown conducted w/ agarose A beads. The binding visualized by immunoblotting. The asterisk denotes the light chain of antibodies. l Lysates of TN-arrested mitotic HeLa cells incubated w/ biotinylated histone peptides & pulled down w/ streptavidin-agarose beads, & the binding visualized by immunoblotting. Relative band intensities of band measured w/ image processing software (Image Studio ver5.0). Error bars, SEMs. Scale bars, 5 μm. Source data are provided as a Source Data file. (Student’s t-test *p < 0.01). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32001712), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-89951_rabbit-polyclonal-borealin-antibody-310202416113528.jpg)
![Western Blot: Borealin Antibody [NBP1-89951] - Aurora B preferentially binds to H3R2me2a & recruits CPC components.a The amino acid sequences of modified histone H3 peptides. b In vitro Haspin kinase assay w/ 21-aa peptide. c In vitro Aurora B kinase assay w/ 21-aa peptide for phosphorylation. d In vitro PRMT6 methyltransferase assay. e–h The cells treated w/ siPRMT6, PRMT6 inhibitor MS023, or the Haspin kinase inhibitor CHR-6494. The intensities of H3R2me2a (f) & H3T3ph (h) in chromosome arm & centromere analyzed by IF microscopy of nocodazole-arrested HeLa chromosome spreads & plotted (n = 100 chromosomes from three independent experiments). i After transfection of indicated plasmids, HeLa cells treated w/ a Haspin kinase inhibitor, CHR-6494, for 5 h & the intensity of CPC components analyzed for 100 centromeres from three independent experiments. j Recombinant CPC proteins incubated w/ biotinylated histone peptides & pulled down w/ streptavidin-agarose beads, & the binding visualized by immunoblotting. k Lysates of TN-arrested Aurora B-depleted cells supplemented w/ recombinant Survivin & Borealin proteins w/ or w/out recombinant Aurora B protein. The lysates incubated w/ antibodies against INCENP & the H3R2me2a peptide, & pulldown conducted w/ agarose A beads. The binding visualized by immunoblotting. The asterisk denotes the light chain of antibodies. l Lysates of TN-arrested mitotic HeLa cells incubated w/ biotinylated histone peptides & pulled down w/ streptavidin-agarose beads, & the binding visualized by immunoblotting. Relative band intensities of band measured w/ image processing software (Image Studio ver5.0). Error bars, SEMs. Scale bars, 5 μm. Source data are provided as a Source Data file. (Student’s t-test *p < 0.01). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32001712), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-89951_rabbit-polyclonal-borealin-antibody-310202416121943.jpg)
![Immunohistochemistry-Paraffin: ER alpha/NR3A1 Antibody [NBP1-84827] - Analysis in human endometrium and cerebral cortex tissues. Corresponding ER alpha/NR3A1 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-Immunohistochemistry-Paraffin-NBP1-84827-img0018.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: ER alpha/NR3A1 Antibody [NBP1-84827] - Analysis in human endometrium and cerebral cortex tissues. Corresponding ER alpha/NR3A1 RNA-seq data are presented for the same tissues.")
![<b>Independent Antibodies Validation and Orthogonal Strategies Validation.</b>Immunohistochemistry-Paraffin: ER alpha/NR3A1 Antibody [NBP1-84827] - Staining of human cerebral cortex, cervix, uterine, endometrium and gastrointestinal using Anti-ER alpha/NR3A1 antibody NBP1-84827 (A) shows similar protein distribution across tissues to independent antibody NBP1-84826 (B).](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-Immunohistochemistry-Paraffin-NBP1-84827-img0021.jpg)
![Immunocytochemistry/Immunofluorescence: ER alpha/NR3A1 Antibody [NBP1-84827] - Staining of human cell line MCF7 shows localization to nucleus & vesicles. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-84827-img0006.jpg)
![Immunohistochemistry-Paraffin: ER alpha/NR3A1 Antibody [NBP1-84827] - Staining of human uterine cervix shows strong nuclear positivity in squamous epithelial cells.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-Immunohistochemistry-Paraffin-NBP1-84827-img0024.jpg)
![Immunohistochemistry-Paraffin: ER alpha/NR3A1 Antibody [NBP1-84827] - Staining of human cerebral cortex shows no positivity in neurons as expected.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-Immunohistochemistry-Paraffin-NBP1-84827-img0019.jpg)
![Immunohistochemistry-Paraffin: ER alpha/NR3A1 Antibody [NBP1-84827] - Staining of human endometrium shows strong nuclear positivity in glandular cells.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-Immunohistochemistry-Paraffin-NBP1-84827-img0022.jpg)
![Immunohistochemistry-Paraffin: ER alpha/NR3A1 Antibody [NBP1-84827] - Staining of human small intestine shows no positivity in glandular cells as expected.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-Immunohistochemistry-Paraffin-NBP1-84827-img0023.jpg)
![Immunocytochemistry/Immunofluorescence: CD14 Antibody [NBP1-86168] - Staining of human cell line SiHa shows localization to vesicles. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/CD14-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-86168-img0007.jpg "Immunocytochemistry/Immunofluorescence: CD14 Antibody [NBP1-86168] - Staining of human cell line SiHa shows localization to vesicles. Antibody staining is shown in green.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD14 Antibody [NBP1-86168] - Analysis in human lymph node and pancreas tissues. Corresponding CD14 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD14-Antibody-Immunohistochemistry-Paraffin-NBP1-86168-img0016.jpg)
![<b>Independent Antibodies Validation. </b>Immunohistochemistry-Paraffin: CD14 Antibody [NBP1-86168] - Staining of human liver, lymph node, pancreas and rectum using Anti-CD14 antibody NBP1-86168 (A) shows similar protein distribution across tissues to independent antibody NBP1-86166 (B).](http://images.novusbio.com/fullsize/CD14-Antibody-Immunohistochemistry-Paraffin-NBP1-86168-img0014.jpg)
![Immunohistochemistry-Paraffin: CD14 Antibody [NBP1-86168] - Staining of human tonsil shows moderate membranous positivity in germinal center cells.](http://images.novusbio.com/fullsize/CD14-Antibody-Immunohistochemistry-Paraffin-NBP1-86168-img0021.jpg)
![Immunohistochemistry-Paraffin: CD14 Antibody [NBP1-86168] - Staining of human rectum shows moderate to strong cytoplasmic positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD14-Antibody-Immunohistochemistry-Paraffin-NBP1-86168-img0017.jpg)
![Immunohistochemistry-Paraffin: CD14 Antibody [NBP1-86168] - Staining of human pancreas shows no cytoplasmic positivity in exocrine glandular cells as expected.](http://images.novusbio.com/fullsize/CD14-Antibody-Immunohistochemistry-Paraffin-NBP1-86168-img0018.jpg)
![Immunohistochemistry-Paraffin: CD14 Antibody [NBP1-86168] - Staining of human lymph node shows moderate to strong membranous positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD14-Antibody-Immunohistochemistry-Paraffin-NBP1-86168-img0019.jpg)
![Immunohistochemistry-Paraffin: CD14 Antibody [NBP1-86168] - Staining of human liver shows moderate to strong membranous positivity in hepatic sinusoid cells.](http://images.novusbio.com/fullsize/CD14-Antibody-Immunohistochemistry-Paraffin-NBP1-86168-img0020.jpg)
![Western Blot: USP10 Antibody (OTI2E1) [NBP2-01452] - Equivalent amounts of cell lysates (10 ug per lane) of wild-type Hela cells (WT) and USP10-Knockout Hela cells (KO) were separated by SDS-PAGE and immunoblotted with anti-USP10 monoclonal antibody NBP2-01452, (1:500). Then the blotted membrane was stripped and reprobed with an anti-beta-actin antibody as a loading control.](http://images.novusbio.com/fullsize/USP10-Antibody-OTI2E1-Western-Blot-NBP2-01452-img0013.jpg "<b>Genetic Strategies Validation. </b>Western Blot: USP10 Antibody (OTI2E1) [NBP2-01452] - Equivalent amounts of cell lysates (10 ug per lane) of wild-type Hela cells (WT) and USP10-Knockout Hela cells (KO) were separated by SDS-PAGE and immunoblotted with anti-USP10 monoclonal antibody NBP2-01452, (1:500). Then the blotted membrane was stripped and reprobed with an anti-beta-actin antibody as a loading control.")
![<b>Genetic Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: USP10 Antibody (2E1) [NBP2-01452] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY USP10.](http://images.novusbio.com/fullsize/USP10-Antibody-2E1-Immunocytochemistry-Immunofluorescence-NBP2-01452-img0010.jpg)
![Immunohistochemistry-Paraffin: USP10 Antibody (OTI2E1) [NBP2-01452] - Immunohistochemical staining of paraffin-embedded Human tonsil within the normal limits using anti-USP10 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100 degrees C for 10min, NBP2-01452)](http://images.novusbio.com/fullsize/USP10-Antibody-OTI2E1-Immunohistochemistry-Paraffin-NBP2-01452-img0012.jpg)
![Flow Cytometry: USP10 Antibody (2E1) [NBP2-01452] - Analysis of Hela cells, using anti-USP10 antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/USP10-Antibody-2E1-Flow-Cytometry-NBP2-01452-img0001.jpg)
![Western Blot: USP10 Antibody (2E1) [NBP2-01452] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY USP10 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-USP10.](http://images.novusbio.com/fullsize/USP10-Antibody-2E1-Western-Blot-NBP2-01452-img0002.jpg)
![Western Blot: USP10 Antibody (2E1) [NBP2-01452] Analysis of extracts (35ug) from 9 different cell lines by using anti-USP10 monoclonal antibody.](http://images.novusbio.com/fullsize/USP10-Antibody-2E1-Western-Blot-NBP2-01452-img0011.jpg)
![Immunohistochemistry-Paraffin: USP10 Antibody (2E1) [NBP2-01452] - Staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-USP10 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/USP10-Antibody-2E1-Immunohistochemistry-Paraffin-NBP2-01452-img0003.jpg)
![Immunohistochemistry-Paraffin: USP10 Antibody (2E1) [NBP2-01452] - Staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-USP10 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/USP10-Antibody-2E1-Immunohistochemistry-Paraffin-NBP2-01452-img0004.jpg)
![Immunohistochemistry-Paraffin: USP10 Antibody (2E1) [NBP2-01452] - Staining of paraffin-embedded Human breast tissue using anti-USP10 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/USP10-Antibody-2E1-Immunohistochemistry-Paraffin-NBP2-01452-img0005.jpg)
![Immunohistochemistry-Paraffin: USP10 Antibody (2E1) [NBP2-01452] - Staining of paraffin-embedded Human endometrium tissue using anti-USP10 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/USP10-Antibody-2E1-Immunohistochemistry-Paraffin-NBP2-01452-img0006.jpg)
![Immunohistochemistry-Paraffin: USP10 Antibody (2E1) [NBP2-01452] - Staining of paraffin-embedded Human lymphoma tissue using anti-USP10 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/USP10-Antibody-2E1-Immunohistochemistry-Paraffin-NBP2-01452-img0007.jpg)
![Immunohistochemistry-Paraffin: USP10 Antibody (2E1) [NBP2-01452] - Staining of paraffin-embedded Human pancreas tissue using anti-USP10 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/USP10-Antibody-2E1-Immunohistochemistry-Paraffin-NBP2-01452-img0008.jpg)
![Immunohistochemistry-Paraffin: USP10 Antibody (2E1) [NBP2-01452] - Staining of paraffin-embedded Human prostate tissue using anti-USP10 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/USP10-Antibody-2E1-Immunohistochemistry-Paraffin-NBP2-01452-img0009.jpg)
![Western Blot: Spectrin beta 1 Antibody (4C3) [NB300-574] - Analysis of 25 ug of Hela cell lysates.](http://images.novusbio.com/fullsize/Spectrin-beta-1-Antibody-4C3-Western-Blot-NB300-574-img0009.jpg "Western Blot: Spectrin beta 1 Antibody (4C3) [NB300-574] - Analysis of 25 ug of Hela cell lysates.")
![Immunocytochemistry/Immunofluorescence: Spectrin beta 1 Antibody (4C3) [NB300-574] - Analysis of Spectrin beta-1 (green) showing staining in the cytoplasm of A431 cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/Spectrin-beta-1-Antibody-4C3-Immunocytochemistry-Immunofluorescence-NB300-574-img0005.jpg)
![Immunohistochemistry: Spectrin beta 1 Antibody (4C3) [NB300-574] - Neu5Gc co-staining with beta spectrin, CD11b, CD8 or Pax7 in normal, BMD or DMD human muscle. Otherwise normal, Becker muscular dystrophy (BMD) and Duchenne muscular dystrophy (DMD) muscle biopsy sections were stained for Neu5Gc (green),Spectrin beta 1 (red) and DAPI (blue). Arrows indicate Neu5Gc puncta in cytoplasmic or perimembranous regions of BMD and DMD skeletal myofibers. Bar is 50 um for all panels. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0088226) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Spectrin-beta-1-Antibody-4C3-Immunohistochemistry-NB300-574-img0010.jpg)
![Flow Cytometry: Spectrin beta 1 Antibody (4C3) [NB300-574] - Analysis of Hela cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/Spectrin-beta-1-Antibody-4C3-Flow-Cytometry-NB300-574-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: Spectrin beta 1 Antibody (4C3) [NB300-574] - Analysis of Spectrin beta-1 (green) showing staining in the cytoplasm of Hela cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/Spectrin-beta-1-Antibody-4C3-Immunocytochemistry-Immunofluorescence-NB300-574-img0004.jpg)
![Immunohistochemistry-Paraffin: Spectrin beta 1 Antibody (4C3) [NB300-574] - Analysis showing positive staining in the membrane of Human skeletal muscle (right) compared with a negative control in the absence of primary antibody (left).](http://images.novusbio.com/fullsize/Spectrin-beta-1-Antibody-4C3-Immunohistochemistry-Paraffin-NB300-574-img0006.jpg)
![Immunohistochemistry-Paraffin: Spectrin beta 1 Antibody (4C3) [NB300-574] - Analysis showing positive staining in the cytoplasm of Human prostate carcinoma (right) compared with a negative control in the absence of primary antibody (left).](http://images.novusbio.com/fullsize/Spectrin-beta-1-Antibody-4C3-Immunohistochemistry-Paraffin-NB300-574-img0007.jpg)
![Immunohistochemistry-Paraffin: Spectrin beta 1 Antibody (4C3) [NB300-574] - Analysis showing positive staining in the cytoplasm and membrane of Mouse skeletal muscle (right) compared with a negative control in the absence of primary antibody (left).](http://images.novusbio.com/fullsize/Spectrin-beta-1-Antibody-4C3-Immunohistochemistry-Paraffin-NB300-574-img0008.jpg)
![Flow Cytometry: Spectrin beta 1 Antibody (4C3) [NB300-574] - Analysis of SH-SY5Y cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/Spectrin-beta-1-Antibody-4C3-Flow-Cytometry-NB300-574-img0001.jpg)
![Flow Cytometry: Spectrin beta 1 Antibody (4C3) [NB300-574] - Analysis of NIH/3T3 cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/Spectrin-beta-1-Antibody-4C3-Flow-Cytometry-NB300-574-img0002.jpg)
![Immunocytochemistry/ Immunofluorescence: Spectrin beta 1 Antibody (4C3) [NB300-574] - Neu5Gc co-staining with beta spectrin, CD11b, CD8 or Pax7 in normal, BMD or DMD human muscle.(A) Otherwise normal, Becker muscular dystrophy (BMD) & Duchenne muscular dystrophy (DMD) muscle biopsy sections were stained for Neu5Gc (green), beta spectrin (red) & DAPI (blue). Arrows indicate Neu5Gc puncta in cytoplasmic or perimembranous regions of BMD & DMD skeletal myofibers. (B) DMD muscle was co-stained for Neu5Gc & CD11b, CD8 or Pax7 (and DAPI). Bar is 50 µm for all panels in A & B. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/24505439), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb300-574_mouse-monoclonal-spectrin-beta-1-antibody-4c3-310202415392512.jpg)
![Flow Cytometry: CD45 Antibody (HI30) [NBP1-79127] - Surface staining of human peripheral blood cells with anti-human CD45 antibody (HI30) [NBP1-79127] Pacific BlueTM.](http://images.novusbio.com/fullsize/CD45-Antibody-HI30-Flow-Cytometry-NBP1-79127-img0007.jpg "Flow Cytometry: CD45 Antibody (HI30) [NBP1-79127] - Surface staining of human peripheral blood cells with anti-human CD45 antibody (HI30) [NBP1-79127] Pacific BlueTM.")
![Flow (Cell Surface): CD45 Antibody (HI30) [NBP1-79127] - hPBMC cells were stained with CD45 antibody (HI30) [NBP1-79127] (blue) and a matched isotype control [NBP2-27287] (orange). Cells were incubated in an antibody dilution of 1 ug/mL for 20 minutes at room temperature. The antibodies were directly conjugated to Alexa Flour 488.](http://images.novusbio.com/fullsize/CD45-Antibody-HI30-Flow-Cell-Surface-NBP1-79127-img0005.jpg)
![Flow Cytometry: CD45 Antibody (HI30) [NBP1-79127] - Surface staining of human peripheral blood cells with anti-human CD45 antibody (HI30) [NBP1-79127] Pacific OrangeTM.](http://images.novusbio.com/fullsize/CD45-Antibody-HI30-Flow-Cytometry-NBP1-79127-img0008.jpg)
![Flow Cytometry: CD45 Antibody (HI30) [NBP1-79127] - Surface staining of human peripheral blood cells with anti-human CD45 antibody (HI30) [NBP1-79127] purified, GAM-APC.](http://images.novusbio.com/fullsize/CD45-Antibody-HI30-Flow-Cytometry-NBP1-79127-img0009.jpg)
![Flow Cytometry: CD45 Antibody (HI30) [NBP1-79127] - Analysis of PE/Cy7 conjugate of CD45 antibody (HI30) [NBP1-79127]. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control PE-Cy7 (blue histogram) or Anti-Human CD45 PE-Cy7 (purple histogram). Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD45-Antibody-HI30-Flow-Cytometry-NBP1-79127-img0010.jpg)
![Flow (Cell Surface): CD45 Antibody (HI30) [NBP1-79127] - Flow (Cell Surface): Cell surface staining of PBMC's (Lymphocyte gate at 1 x 10^6 cells/ml) with CD45 antibody (HI30) [Alexa Fluor (R) 647] [NBP1-79127AF647] (orange) stained at a dilution of 1:500. Shown with mIgG1 (AF647 conjugated) Isotype control (blue). Image using the Alexa Fluor 647 form of this antibody.](http://images.novusbio.com/fullsize/CD45-Antibody-HI30-Flow-Cell-Surface-NBP1-79127-img0011.jpg)
![Western Blot: ARPC2 Antibody [NB100-1037] - Staining of CACO-2 with antibody at 0.5 ug/mL (A), HeLa (B) and Jurkat (C) lysate with antibody at 0.1 ug/mL (35 ug protein in RIPA buffer). Detected by chemiluminescence.](http://images.novusbio.com/fullsize/ARPC2-Antibody-Western-Blot-NB100-1037-img0003.jpg "Western Blot: ARPC2 Antibody [NB100-1037] - Staining of CACO-2 with antibody at 0.5 ug/mL (A), HeLa (B) and Jurkat (C) lysate with antibody at 0.1 ug/mL (35 ug protein in RIPA buffer). Detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: ARPC2 Antibody [NB100-1037] - Immunofluorescence analysis of paraformaldehyde fixed HeLa cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).](http://images.novusbio.com/fullsize/ARPC2-Antibody-Immunocytochemistry-Immunofluorescence-NB100-1037-img0005.jpg)
![Immunohistochemistry-Paraffin: ARPC2 Antibody [NB100-1037] - Staining of Human Spleen. Steamed antigen retrieval with citrate buffer pH 6, AP-staining. Antibody at 3.8 ug/mL.](http://images.novusbio.com/fullsize/ARPC2-Antibody-Immunohistochemistry-Paraffin-NB100-1037-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: ARPC2 Antibody [NB100-1037] - Immunofluorescence analysis of paraformaldehyde fixed A431 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).](http://images.novusbio.com/fullsize/ARPC2-Antibody-Immunocytochemistry-Immunofluorescence-NB100-1037-img0004.jpg)